Close

Wells Fargo Upgrades BioMarin Pharmaceutical Inc. (BMRN) to Outperform

November 3, 2014 6:48 AM EST
Get Alerts BMRN Hot Sheet
Price: $87.34 -1.43%

Rating Summary:
    22 Buy, 10 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 0
Join SI Premium – FREE

Wells Fargo upgraded BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) from Market Perform to Outperform with a price target of $103-$107 (from $72-$76). Analyst Brian Abrahams is positive ahead of 2015 data. He also thinks the company is an attractive M&A candidate.

For an analyst ratings summary and ratings history on BioMarin Pharmaceutical Inc. click here. For more ratings news on BioMarin Pharmaceutical Inc. click here.

Shares of BioMarin Pharmaceutical Inc. closed at $82.50 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst PT Change, Hot Upgrades, Upgrades

Related Entities

Wells Fargo